Antifungal prophylaxis in lung transplantation

Seminars in Respiratory and Critical Care Medicine

Volumn 32, Issue 6, 2011, Pages 717-726

  Avery, Robin K ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

aspergillosis; Fungal prophylaxis; invasive fungal infections; lung transplant; mold infection

Indexed keywords

AMPHOTERICIN; AMPHOTERICIN B; ANIDULAFUNGIN; ANTIFUNGAL AGENT; CASPOFUNGIN; FLUCONAZOLE; ITRACONAZOLE; MICAFUNGIN; POSACONAZOLE; PYRROLE; SULFAMETHOXAZOLE; TRIMETHOPRIM; VORICONAZOLE;

ARTICLE; ASPERGILLOSIS; ASPERGILLUS; CANDIDA; CANDIDIASIS; CLINICAL FEATURE; CRYPTOCOCCOSIS; CRYPTOCOCCUS; EMPYEMA; ENDEMIC DISEASE; FUNGAL COLONIZATION; HUMAN; INCIDENCE; LIVER FUNCTION TEST; LIVER TOXICITY; LUNG DISEASE; LUNG TRANSPLANTATION; MULTIPLE CANCER; MYCOSIS; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK FACTOR; SIDE EFFECT;

ANTIFUNGAL AGENTS; CHEMOPREVENTION; FUNGI; HUMANS; IMMUNOCOMPROMISED HOST; LUNG DISEASES, FUNGAL; LUNG TRANSPLANTATION; OPPORTUNISTIC INFECTIONS;

EID: 83655191221     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0031-1295719     Document Type: Article

References (70)

1. Singh N, Husain S, AST Infectious Diseases Community of Practice. Invasive aspergillosis in solid organ transplant recipients. Am J Transplant 2009 9 Suppl 4 S180-S191
2. Husain S, Paterson D L., Studer S et al. Voriconazole prophylaxis in lung transplant recipients. Am J Transplant 2006 6 12 3008-3016
3. Husain S, Mooney M L., Danziger-Isakov L et al. A 2010 working formulation for the standardization of definitions of infections in cardiothoracic transplant recipients. J Heart Lung Transplant 2011 30 4 361-374
4. Kubak B M. Fungal infection in lung transplantation. Transpl Infect Dis 2002 4 Suppl 3 24-31 (Pubitemid 34832433)
5. Danziger-Isakov L A., Worley S, Arrigain S et al. Increased mortality after pulmonary fungal infection within the first year after pediatric lung transplantation. J Heart Lung Transplant 2008 27 6 655-661
6. Pappas P G., Alexander B D., Andes D R. et al. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010 50 8 1101-1111
7. Husain S, Zaldonis D, Kusne S, Kwak E J., Paterson D L., McCurry K R. Variation in antifungal prophylaxis strategies in lung transplantation. Transpl Infect Dis 2006 8 4 213-218 (Pubitemid 44787860)
8. Neoh C F., Snell G I., Kotsimbos T et al. Antifungal prophylaxis in lung transplantationa world-wide survey. Am J Transplant 2011 11 2 361-366
9. Singh N, Husain S. Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for management. J Heart Lung Transplant 2003 22 3 258-266 (Pubitemid 36300817)
10. Husni R N., Gordon S M., Longworth D L. et al. Cytomegalovirus infection is a risk factor for invasive aspergillosis in lung transplant recipients. Clin Infect Dis 1998 26 3 753-755 (Pubitemid 28155032)
11. Cahill B C., Hibbs J R., Savik K et al. Aspergillus airway colonization and invasive disease after lung transplantation. Chest 1997 112 5 1160-1164 (Pubitemid 27497842)
12. Flume P A., Egan T M., Paradowski L J., Detterbeck F C., Thompson J T., Yankaskas J R. Infectious complications of lung transplantation. Impact of cystic fibrosis. Am J Respir Crit Care Med 1994 149 6 1601-1607 (Pubitemid 24175982)
13. Husain S. Unique characteristics of fungal infections in lung transplant recipients. Clin Chest Med 2009 30 2 307-313, vii
14. Choong C K., Sweet S C., Zoole J B. et al. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome. J Thorac Cardiovasc Surg 2006 131 1 198-203 (Pubitemid 43049801)
15. Cuellar-Rodriguez J, Avery R K., Lard M et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009 49 5 710-716
16. Hadjiliadis D, Sporn T A., Perfect J R., Tapson V F., Davis R D., Palmer S M. Outcome of lung transplantation in patients with mycetomas. Chest 2002 121 1 128-134 (Pubitemid 34114237)
17. Weigt S S., Elashoff R M., Huang C et al. Aspergillus colonization of the lung allograft is a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2009 9 8 1903-1911
18. Estenne M, Maurer J R., Boehler A et al. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002 21 3 297-310 (Pubitemid 34224094)
19. Valentine V G., Gupta M R., Walker J E. Jr et al. Effect of etiology and timing of respiratory tract infections on development of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2009 28 2 163-169
20. Valentine V G., Bonvillain R W., Gupta M R. et al. Infections in lung allograft recipients: ganciclovir era. J Heart Lung Transplant 2008 27 5 528-535
21. Liu M, Worley S, Mallory G B. Jr et al. Fungal infections in pediatric lung transplant recipients: colonization and invasive disease. J Heart Lung Transplant 2009 28 11 1226-1230
22. Luong M L., Morrissey O, Husain S. Assessment of infection risks prior to lung transplantation. Curr Opin Infect Dis 2010 23 6 578-583
23. Issa N C., Fishman J A. Infectious complications of antilymphocyte therapies in solid organ transplantation. Clin Infect Dis 2009 48 6 772-786
24. Peddi V R., Hariharan S, Schroeder T J., First M R. Role of granulocyte colony stimulating factor (G-CSF) in reversing neutropenia in renal allograft recipients. Clin Transplant 1996 10 1 Pt 1 20-23 (Pubitemid 26076422)
25. Palmer S M., Limaye A P., Banks M et al. Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial. Ann Intern Med 2010 152 12 761-769
26. Goldfarb N S., Avery R K., Goormastic M et al. Hypogammaglobulinemia in lung transplant recipients. Transplantation 2001 71 2 242-246 (Pubitemid 32126107)
27. Jordan S C., Toyoda M, Kahwaji J, Vo A A. Clinical aspects of intravenous immunoglobulin use in solid organ transplant recipients. Am J Transplant 2011 11 2 196-202
28. Husain S, Raza K, Pilewski J M. et al. Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection. Transplantation 2009 87 12 1852-1857
29. Kanj S S., Tapson V, Davis R D., Madden J, Browning I. Infections in patients with cystic fibrosis following lung transplantation. Chest 1997 112 4 924-930 (Pubitemid 27446310)
30. Gordon S M., LaRosa S P., Kalmadi S et al. Should prophylaxis for Pneumocystis carinii pneumonia in solid organ transplant recipients ever be discontinued? Clin Infect Dis 1999 28 2 240-246
31. Palmer S M., Perfect J R., Howell D N. et al. Candidal anastomotic infection in lung transplant recipients: successful treatment with a combination of systemic and inhaled antifungal agents. J Heart Lung Transplant 1998 17 10 1029-1033 (Pubitemid 28499035)
32. Hadjiliadis D, Howell D N., Davis R D. et al. Anastomotic infections in lung transplant recipients. Ann Transplant 2000 5 3 13-19
33. Horvath J, Dummer S, Loyd J, Walker B, Merrill W H., Frist W H. Infection in the transplanted and native lung after single lung transplantation. Chest 1993 104 3 681-685 (Pubitemid 23268931)
34. Dowling R D., Baladi N, Zenati M et al. Disruption of the aortic anastomosis after heart-lung transplantation. Ann Thorac Surg 1990 49 1 118-122 (Pubitemid 20035134)
35. Hamacher J, Spiliopoulos A, Kurt A M., Nicod L P., Geneva Lung Transplantation Group. Pre-emptive therapy with azoles in lung transplant patients. Eur Respir J 1999 13 1 180-186 (Pubitemid 29079241)
36. Minari A, Husni R, Avery R K. et al. The incidence of invasive aspergillosis among solid organ transplant recipients and implications for prophylaxis in lung transplants. Transpl Infect Dis 2002 4 4 195-200 (Pubitemid 36142805)
37. Hosseini-Moghaddam S M., Husain S. Fungi and molds following lung transplantation. Semin Respir Crit Care Med 2010 31 2 222-233
38. Husain S, Alexander B D., Munoz P et al. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 2003 37 2 221-229 (Pubitemid 36930353)
39. Costa S F., Alexander B D. Non-Aspergillus fungal pneumonia in transplant recipients. Clin Chest Med 2005 26 4 675-690, vii (Pubitemid 41563266)
40. Sahi H, Avery R K., Minai O A. et al. Scedosporium apiospermum (Pseudoallescheria boydii) infection in lung transplant recipients. J Heart Lung Transplant 2007 26 4 350-356 (Pubitemid 46498770)
41. Das A, MacLaughlin E F., Ross L A. et al. Paecilomyces variotii in a pediatric patient with lung transplantation. Pediatr Transplant 2000 4 4 328-332
42. Lee J, Yew W W., Chiu C S., Wong P C., Wong C F., Wang E P. Delayed sternotomy wound infection due to Paecilomyces variotii in a lung transplant recipient. J Heart Lung Transplant 2002 21 10 1131-1134 (Pubitemid 35190332)
43. Tamm M, Malouf M, Glanville A. Pulmonary scedosporium infection following lung transplantation. Transpl Infect Dis 2001 3 4 189-194 (Pubitemid 34051919)
44. Ambrosioni J, Bouchuiguir-Wafa K, Garbino J. Emerging invasive zygomycosis in a tertiary care center: epidemiology and associated risk factors. Int J Infect Dis 2010 14 Suppl 3 e100-103
45. Silveira F P., Kwak E J., Paterson D L., Pilewski J M., McCurry K R., Husain S. Post-transplant colonization with non-Aspergillus molds and risk of development of invasive fungal disease in lung transplant recipients. J Heart Lung Transplant 2008 27 8 850-855 (Pubitemid 352020631)
46. Singh N, Forrest G, AST Infectious Diseases Community of Practice. Cryptococcosis in solid organ transplant recipients. Am J Transplant 2009 9 Suppl 4 S192-S198
47. Singh N, Alexander B D., Lortholary O et al. Pulmonary cryptococcosis in solid organ transplant recipients: clinical relevance of serum cryptococcal antigen. Clin Infect Dis 2008 46 2 e12-e18 (Pubitemid 351269182)
48. Singh N, Lortholary O, Alexander B D. et al, Cryptococcal Collaborative Transplant Study Group. An immune reconstitution syndrome-like illness associated with Cryptococcus neoformans infection in organ transplant recipients. Clin Infect Dis 2005 40 12 1756-1761 (Pubitemid 40799944)
49. Kontoyiannis D P., Lewis R E., Alexander B D. et al. Calcineurin inhibitor agents interact synergistically with antifungal agents in vitro against Cryptococcus neoformans isolates: correlation with outcome in solid organ transplant recipients with cryptococcosis. Antimicrob Agents Chemother 2008 52 2 735-738 (Pubitemid 351170854)
50. Miller M B., Hendren R, Gilligan P H. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004 42 5 2347-2349 (Pubitemid 38637883)
51. Tripathy U, Yung G L., Kriett J M., Thistlethwaite P A., Kapelanski D P., Jamieson S W. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002 73 1 306-308 (Pubitemid 34084592)
52. Perfect J R., Dodds Ashley E, Drew R. Design of aerosolized amphotericin b formulations for prophylaxis trials among lung transplant recipients. Clin Infect Dis 2004 39 Suppl 4 S207-S210 (Pubitemid 40169348)
53. Borro J M., Solé A, de la Torre M et al. Efficiency and safety of inhaled amphotericin B lipid complex (Abelcet) in the prophylaxis of invasive fungal infections following lung transplantation. Transplant Proc 2008 40 9 3090-3093
54. Palmer S M., Drew R H., Whitehouse J D. et al. Safety of aerosolized amphotericin B lipid complex in lung transplant recipients. Transplantation 2001 72 3 545-548 (Pubitemid 32769650)
55. Reichenspurner H, Gamberg P, Nitschke M et al. Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis. Transplant Proc 1997 29 1-2 627-628 (Pubitemid 27123555)
56. Drew R H., Dodds Ashley E, Benjamin D K. Jr, Duane Davis R, Palmer S M., Perfect J R. Comparative safety of amphotericin B lipid complex and amphotericin B deoxycholate as aerosolized antifungal prophylaxis in lung-transplant recipients. Transplantation 2004 77 2 232-237 (Pubitemid 38155752)
57. Lowry C M., Marty F M., Vargas S O. et al. Safety of aerosolized liposomal versus deoxycholate amphotericin B formulations for prevention of invasive fungal infections following lung transplantation: a retrospective study. Transpl Infect Dis 2007 9 2 121-125 (Pubitemid 46669088)
58. Corcoran T E., Venkataramanan R, Mihelc K M. et al. Aerosol deposition of lipid complex amphotericin-B (Abelcet) in lung transplant recipients. Am J Transplant 2006 6 11 2765-2773 (Pubitemid 44571699)
59. Monforte V, Ussetti P, López R et al. Nebulized liposomal amphotericin B prophylaxis for Aspergillus infection in lung transplantation: pharmacokinetics and safety. J Heart Lung Transplant 2009 28 2 170-175
60. Husain S, Capitano B, Corcoran T et al. Intrapulmonary disposition of amphotericin B after aerosolized delivery of amphotericin B lipid complex (Abelcet; ABLC) in lung transplant recipients. Transplantation 2010 90 11 1215-1219
61. Monforte V, Román A, Gavaldà J et al. Contamination of the nebulization systems used in the prophylaxis with amphotericin B nebulized in lung transplantation. Transplant Proc 2005 37 9 4056-4058 (Pubitemid 43015252)
62. Shitrit D, Ollech J E., Ollech A et al. Itraconazole prophylaxis in lung transplant recipients receiving tacrolimus (FK 506): efficacy and drug interaction. J Heart Lung Transplant 2005 24 12 2148-2152 (Pubitemid 41814739)
63. Han K, Capitano B, Bies R et al. Bioavailability and population pharmacokinetics of voriconazole in lung transplant recipients. Antimicrob Agents Chemother 2010 54 10 4424-4431
64. Cadena J, Levine D J., Angel L F. et al. Antifungal prophylaxis with voriconazole or itraconazole in lung transplant recipients: hepatotoxicity and effectiveness. Am J Transplant 2009 9 9 2085-2091
65. Mattner F, Chaberny I F., Weissbrodt H et al. [Surveillance of invasive mold infections in lung transplant recipients: effect of antimycotic prophylaxis with itraconazole and voriconazole]. Mycoses 2005 48 Suppl 1 51-55 (Pubitemid 40592868)
66. Mattner F, Weissbrodt H, Strueber M. Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 2004 36 4 312-314 (Pubitemid 38714188)
67. Calvo V, Borro J M., Morales P et al, Valencia Lung Transplant Group. Antifungal prophylaxis during the early postoperative period of lung transplantation. Chest 1999 115 5 1301-1304 (Pubitemid 29230637)
68. Eriksson M, Lemström K, Suojaranta-Ylinen R et al. Control of early Aspergillus mortality after lung transplantation: outcome and risk factors. Transplant Proc 2010 42 10 4459-4464
69. Boehler A, Vogt P, Zollinger A, Weder W, Speich R. Prospective study of the value of transbronchial lung biopsy after lung transplantation. Eur Respir J 1996 9 4 658-662 (Pubitemid 26167867)
70. Silveira F P., Husain S. Fungal infections in lung transplant recipients. Curr Opin Pulm Med 2008 14 3 211-218 (Pubitemid 351572322)